Jennifer L. Carter, Director at Oncocyte Corp (OCX), bought 20,500 shares at $0.95 ($10K) on 2022-08-16, disclosed to the SEC on 2022-08-17.
Open-market purchase of $10k OCX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,000 | $0 | 0.0% |
| 2 | $0.95 | 10,500 | $10K | 100.0% |
| Total | $0.49 avg | 20,500 | $10K | 100% |